Home
The Problem
Our Solution
Mosaic
About Us
Journey
Team
Advisory Board
Investors
Contact
Home
The Problem
Our Solution
Mosaic
About Us
Journey
Team
Advisory Board
Investors
Contact
Investor Centre
Annual Reports
Annual Report FY25
Annual Report FY24
Annual Report FY23
Annual Report FY22
Corporate Governance
Constitution
Employee Incentive Omnibus Plan
2025 AGM Notice of Meeting
- Mosaic V1 is now cleared for use by the FDA -
